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The overall QSP modeling strategy. The constructed QSP model includes both a PK module and a PD module. The PK module describes the distribution and decay of different drugs. The PD module specifies the proliferation, transformation, and death of the trophic forms and asci of Pneumocystis fungi. After construction of the PK module, this module was validated with independent data that were not used for its construction. For the PD module, all available data were used for its construction. The integrated QSP model, which includes both the PK module and the PD module, was constructed with the distribution of asci and trophic forms following treatment and then validated with their temporal dynamics Fig. 2 The structure of the QSP model. Left panel: A three-compartment PK module was used to describe the reported pharmacokinetic data. The first compartment was the AC, the second compartment was plasma, and the third was 'peripheral tissue'. Drug decay was assumed to occur in plasma and 'peripheral tissue' compartments. The rates of drug distribution and decay were described by the corresponding parameters. Right panel: The dynamics of Pneumocystis were described by a two-stage model which involves both trophic forms and asci. The temporal changes of trophic forms and asci were also controlled by the indicated parameters. The drug effects were indicated by arrows (promoting) and 489 lines with solid circle heads (inhibiting) The PD modules were consistent with experimental data from diverse sources. a Temporal simulations for the dynamic changes of trophic form (black curves) and asci (red curves) starting from an initial state with a high level of trophic forms and a low level of asci. b Temporal simulations (black curves) of the normalized total number of Pneumocystis were compared to the normalized nuclei count from Pneumocystis infected mice (red dots, error bars represent SEM, n=2 or 3 for each time point). c and d Histograms showing the distributions of the numbers of the trophic form and asci simulated by the PD module Fig. 6 The simulations of the QSP models were consistent to relevant data. a and b. Bar plots of average simulated log10 levels: of asci (a) and trophic forms (b) at day 56 post-treatment of Pneumocystis from: untreated mice (Control), mice treated with varying doses of anidulafungin, caspofungin and micafungin; as well as mice treated with TMP-SMX. Corresponding experimental data are represented as dot plots with standard error. c The simulated dynamic changes of the trophic forms (black curves) and asci (red curves), on a log10 scale were consistent to the corresponding experimental data (black and red dots) following anidulafungin treatment. d The simulated dynamic changes of trophic forms (black curves) and asci (red curves) were consistent to the corresponding data (black dots and red dots) following TMP-SMX treatment The constructed PK module was validated against independent data Figure 5 Figure 3 The PK modules predict novel PK profiles Figure 6 Figure 4
The constructed PD modules were consistent with multiple experimental observation Figure 3 
